RecallDepth
Class II Ongoing

Duloxetine Delayed-Release Capsules USP, 60 mg, 1000-count bottles, Rx Only, Manufactured by Towa Pharmaceutical Europe, S.L., Distributed by Breckenridge Pharmaceutical, Inc. Berkeley Heights, NJ 07922, NDC# 51991-748-10

This recall is currently active, issued April 30, 2025. It was issued by Breckenridge Pharmaceutical, Inc.

Company
Breckenridge Pharmaceutical, Inc
Recall Initiated
April 14, 2025
Posted
April 30, 2025
Recall Number
D-0387-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
16,473 bottles
Firm Location
Berlin, CT, United States
Official Source
View on FDA website ↗

Reason for Recall

CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.

Distribution

US Nationwide.

Lot / Code Info

Lot # 240987C, exp. date 04/2027 241014C, exp. date 04/2027

More recalls by Breckenridge Pharmaceutical, Inc

View all recalls by this company →

Other recent Class II Drug recalls